Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Jan Medical (Mountain View, CA) a development-stage medical device company focused on a brain sensing device for the timely determination of ischemic stroke, closed a $3.1M Series A financing. Participants include Brainlab. The 2Q11 OnBioVC Trend Analysis will be published on Tue 6 September. Advertising opportunities are still available. Reach >45,000 high-value targeted life science […]

RF Biocidics (Boston, MA) a development-stage device company focused on the elimination of food related pathogens and fungi, closed a $10M Series B financing. Participants include Allied Minds and Invesco Asset Management.

CryoXtract (Arlington, VA) a development-stage device company focused on an automated biobanking frozen sample aliquotter, closed a $3M Series A financing. Participants include Allied Minds. The 2Q11 OnBioVC Trend Analysis will be published on Tue 6 September. Advertising opportunities are still available. Reach >45,000 high-value targeted life science professionals on-line and in-print. Contact arubenstein@rnaventures.com for […]

Milestone Pharmaceuticals (Canada) a development-stage pharmaceutical company focused on small molecules for atrial arrhythmias and angina, closed a $13M Series B financing. Participants include Pappas Ventures, GO Capital, Fonds de solidarité FTQ, iNovia Healthcare Ventures and Fonds Bio-Innovation. The 2Q11 OnBioVC Trend Analysis will be published on Tue 6 September. Advertising opportunities are still available. […]

Advance Medical (Palo Alto, CA) a commercial-stage company focused on the Latin American markets to delivery of an aesthetic medical device for the reduction of fat and other products, closed a $6M Series A financing. Participants include Venrock.

ProtonMedia (Landsdale, PA) a commercial-stage cloud-based life science product lifecycle project management platform, closed a $4.5M Series B financing. Participants include Kaplan Ventures. The 2Q11 OnBioVC Trend Analysis will be published on Tue 6 September. Advertising opportunities are still available. Reach >45,000 high-value targeted life science professionals on-line and in-print. Contact arubenstein@rnaventures.com for details.

Ambit Biosciences (San Diego, CA) a clinical-stage biopharmaceutical company focused on kinase inhibitors for the treatment of cancer and other conditions, closed a $30M Series D financing. Participants include Apposite Capital, Perseus-Soros Biopharmaceutical Fund, OrbiMed, Forward Ventures, Roche Venture Fund, MedImmune Ventures, Gimv, GrowthWorks, GeneChem, Radius Ventures and NovaQuest Capital Management. The 2Q11 OnBioVC Trend […]

Adaptive TCR (Seattle, WA) a commercial-stage provider of online solutions for large scale immune system profiling, closed a $5.8M Series B financing, bringing the total round to $10.3M. Participants were not identified. The 2Q11 OnBioVC Trend Analysis will be published on Tue 6 September. Advertising opportunities are still available. Reach >45,000 high-value targeted life science […]

Access Scientific (San Diego, CA) a commercial-stage medical device company focused on an over-wire vascular micro-access wand, closed a $10M Series C financing. Participants were not identified. The 2Q11 OnBioVC Trend Analysis will be published on Tue 6 September. Advertising opportunities are still available. Reach >45,000 high-value targeted life science professionals on-line and in-print. Contact […]

Stratos Genomics (Seattle, WA) a development-stage device company focused on a ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics, closed a $2.1M Series A financing, bringing the total round to $6.1M. Participants have included Fisk Ventures. The 2Q11 OnBioVC Trend Analysis will be published on Tue 6 September. Advertising opportunities are […]

Constellation Pharmaceuticals (Cambridge, MA) a development-stage biopharma focused on small molecule therapeutics against chromatin-based targets to treat cancer and inflammatory disorders, closed a $15M Series B financing bringing the total round to $37M. Participants include S.R. One, Altitude Life Science Ventures, Third Rock Ventures, The Column Group and Venrock. The 2Q11 OnBioVC Trend Analysis will […]

Enerkem (Canada) a development-stage waste-to-biofuels and chemicals company, closes a $60M Series C financing. Participants include Valero Energy, Waste Management, Rho Ventures, Braemar Energy Ventures and Cycle Capital. The 2Q11 OnBioVC Trend Analysis will be published on Tue 6 September. Advertising opportunities are still available. Reach >45,000 high-value targeted life science professionals on-line and in-print. […]

Avantium (Netherlands) a commercial-stage clinical research organization focused on high-throughput R&D, closed a $36.2M Series B financing. Participants include Sofinnova Partners, Aster Capital, De Hoge Dennen, Aescap Venture, Capricorn Cleantech Fund, ING Corporate Investments and Navitas Capital. The 2Q11 OnBioVC Trend Analysis will be published on Tue 6 September. Advertising opportunities are still available. Reach […]

« Previous Entries  Next Page »

to top of page...